Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions
Multiple myeloma (MM) is a life-threatening haematological malignancy for which standard therapy is inadequate. Autologous stem cell transplantation is a relatively effective treatment, but residual malignant sites may cause relapse. Allogeneic transplantation may result in durable responses due t...
Saved in:
| Main Authors: | Ivetta Danylesko, Katia Beider, Avichai Shimoni, Arnon Nagler |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2012/753407 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy for Multiple Myeloma
by: Nicolaus Kröger, et al.
Published: (2012-01-01) -
Microbiome-based prediction of allogeneic hematopoietic stem cell transplantation outcome
by: Oshrit Shtossel, et al.
Published: (2025-07-01) -
Targeting BCMA in multiple myeloma: designs, challenges, and future directions
by: Yi Hu, et al.
Published: (2025-02-01) -
World Kidney Day; previous experience influences future directions
by: Samaneh Zandifar, et al.
Published: (2024-03-01) -
Lipid metabolism in multiple myeloma: pathogenesis, therapeutic opportunities, and future directions
by: Huiquan Wang, et al.
Published: (2025-03-01)